FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Jenkins

Research Profile

Procedures

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Alvaro Moreno-Aspitia; Donald Northfelt; Frances M Palmieri; Tejal Patel; Richard Rodeheffer; Kathleen S Tenner; Gerardo Colon-Otero; Shaker Dakhil; Amylou C Dueck; Sandra Franco; Ismael Ghanem-Cañete; Robert B Jenkins; David Johnson; Stephen Kahanic; Ann E McCullough; Edith A Perez
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
Edith A Perez; Michael F Press; Monica M Reinholz; Mona Shing; Howard M Stern; Ivonne Villalobos; Anne E Wiktor; Joanne Zujewski; Marc Buyse; Beiyun Chen; Amylou C Dueck; Melanie Finnigan; Robert B Jenkins; Chungyeul Kim; Wilma L Lingle; Reid Meyer; Soonmyung Paik; Dennis J Slamon
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
Kyle M Walsh; Joe L Wiemels; John K Wiencke; Yuanyuan Xiao; Shichun Zheng; Erik Anderson; Paige M Bracci; Jeffrey S Chang; Paul A Decker; Jeanette E Eckel-Passow; Helen M Hansen; Robert B Jenkins; Thomas Kollmeyer; Matt L Kosel; Daniel H Lachance; Lucie S McCoy; Alexander R Pico; Terri Rice; Hugues Sicotte; Ivan Smirnov; Margaret R Wrensch
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Jenkins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alvaro Moreno-Aspitia; Donald Northfelt; Frances M Palmieri; Tejal Patel; Richard Rodeheffer; Kathleen S Tenner; Gerardo Colon-Otero; Shaker Dakhil; Amylou C Dueck; Sandra Franco; Ismael Ghanem-Cañete; Robert B Jenkins; David Johnson; Stephen Kahanic; Ann E McCullough; Edith A Perez
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.
Breast cancer research and treatment 2013;138(2):427-35.
2013: Edith A Perez; Michael F Press; Monica M Reinholz; Mona Shing; Howard M Stern; Ivonne Villalobos; Anne E Wiktor; Joanne Zujewski; Marc Buyse; Beiyun Chen; Amylou C Dueck; Melanie Finnigan; Robert B Jenkins; Chungyeul Kim; Wilma L Lingle; Reid Meyer; Soonmyung Paik; Dennis J Slamon
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
Breast cancer research and treatment 2013;138(1):99-108.
2013: Kyle M Walsh; Joe L Wiemels; John K Wiencke; Yuanyuan Xiao; Shichun Zheng; Erik Anderson; Paige M Bracci; Jeffrey S Chang; Paul A Decker; Jeanette E Eckel-Passow; Helen M Hansen; Robert B Jenkins; Thomas Kollmeyer; Matt L Kosel; Daniel H Lachance; Lucie S McCoy; Alexander R Pico; Terri Rice; Hugues Sicotte; Ivan Smirnov; Margaret R Wrensch
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
Genetic epidemiology 2013;37(2):222-8.
2012: McKinsey L Goodenberger; Robert B Jenkins
Genetics of adult glioma.
Cancer genetics 2012;205(12):613-21.
2012: Xiangqing Sun; Jaime Vengoechea; Nicholas A Vick; Margaret Wrensch; Ping Yang; Robert Yu; Christopher I Amos; Georgina Armstrong; Jill S Barnholtz-Sloan; Jonine L Bernstein; Melissa L Bondy; Yanwen Chen; Elizabeth Claus; Faith Davis; Robert Elston; Richard S Houlston; Dora Il'yasova; Robert B Jenkins; Christoffer Johansen; Rose Lai; Ching C Lau; Yanhong Liu; Bridget J McCarthy; Beatrice Melin; Ryan Merrell; Sara H Olson; Siegal Sadetzki; Joellen Schildkraut; Sanjay Shete
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(12):2242-51.
2012: Rondell P Graham; Jennelle C Hodge; Robert B Jenkins; Kevin J Meyer; Andre M Oliveira; Franklin H Sim; Andrew L Folpe; William R Sukov
A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.
Human pathology 2012;43(8):1334-8.
2012: Yuanyuan Xiao; Mitchel S Berger; Steve Brem; James E Browning; Jan C Buckner; Susan M Chang; Paul A Decker; Kathleen M Egan; Brooke L Fridley; Helen M Hansen; Robert B Jenkins; Matthew L Kosel; Daniel H Lachance; Melissa H Madden; Lucie S McCoy; L Burt Nabors; Jeffrey J Olson; Brian Patrick O'Neill; Joseph S Patoka; Michael D Prados; Terri Rice; Ivan Smirnov; Reid C Thompson; Tarik Tihan; Joe L Wiemels; John K Wiencke; Margaret R Wrensch
SSBP2 variants are associated with survival in glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(11):3154-62.
2012: Aatur D Singhi; Saraswati Sukumar; Russell Vang; Ashley Cimino-Mathews; Angelo M DeMarzo; John H Fetting; Stephanie R Fink; Jessica Hicks; Robert B Jenkins; Fusheng Lan; HIND NASSAR; Pedram Argani
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(3):378-87.
2012: Edith A Perez; Monica M Reinholz; Kathleen S Tenner; Nancy E Davidson; Amylou Dueck; Julie Gralow; Lyndsay N Harris; David W Hillman; Robert B Jenkins; Leila A Kutteh; Ann E McCullough; Beiyun Chen
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria.
Journal of the National Cancer Institute 2012;104(2):159-62.
2012: Harry H Yoon; William R Sukov; Anne E Wiktor; Tsung-Teh Wu; Robert B Diasio; Axel Grothey; Robert B Jenkins; Maliha Khan; Christopher A Sattler; Qian Shi; Frank A Sinicrope
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(2):546-54.
2011: Sanjay Shete; Nicholas A Vick; Margaret Wrensch; Ping Yang; Robert K Yu; Georgina N Armstrong; Jill S Barnholtz-Sloan; Jonine L Bernstein; Rita Cheng; Elizabeth B Claus; Caleb Davis; Faith G Davis; Roger Henriksson; Fay J Hosking; Richard S Houlston; Dora Il'yasova; Robert B Jenkins; Christoffer Johansen; Rose Lai; Ching C Lau; Eastwood Hon-chiu Leung; Yanhong Liu; Bridget J McCarthy; Beatrice S Melin; Sara H Olson; Siegal Sadetzki; Joellen Schildkraut; Melissa L Bondy
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
Cancer research 2011;71(24):7568-75.
2011: Edith A Perez; Thomas M Pisansky; Vera J Suman; Daniel W Visscher; Joanne Zujewski; Beiyun Chen; Shaker R Dakhil; Nancy E Davidson; Julie R Gralow; James N Ingle; Peter A Kaufman; Alvaro Moreno-Aspitia; Robert B Jenkins
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(34):4491-7.
2011: Abra G Brisbin; Graham Casey; David V Conti; David J Duggan; Jeremiah A Aakre; Yan W Asmann; Steven Gallinger; John Hopper; Mark Jenkins; Robert B Jenkins; Polly Newcomb; Paul Pharoah; Fredrick Schumacher; Thomas A Sellers; Honglin Song; Ya-Yu Tsai; Ping Yang; Brooke L Fridley
Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.
BMC medical genetics 2011;12():156.
2011: Robert B Jenkins; Margaret Wrensch; Derek Johnson; Brooke L Fridley; Paul A Decker; Yuanyuan Xiao; Thomas Kollmeyer; Amanda L Rynearson; Stephanie Fink; Terri Rice; Lucie S McCoy; Chandralekha Halder; Matthew L Kosel; Caterina Giannini; Tarik Tihan; Brian P O'Neill; Daniel H Lachance; Ping Yang; Joseph L Wiemels; John K Wiencke
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Cancer genetics 2011;204(1):13-8.
2010: Antonino B D'Assoro; Alexey Leontovich; Angela Amato; Jennifer R Ayers-Ringler; Cosima Quatraro; Kari Hafner; Robert B Jenkins; Massimo Libra; James Ingle; Franca Stivala; Evanthia C Galanis; Jeffrey Salisbury
Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
International journal of oncology 2010;37(5):1167-76.
2010: Edith A Perez; Monica M Reinholz; David W Hillman; Kathleen S Tenner; Matthew J Schroeder; Nancy E Davidson; Silvana Martino; George W Sledge; Lyndsay N Harris; Julie R Gralow; Amylou Dueck; Rhett P Ketterling; James N Ingle; Wilma L Lingle; Peter A Kaufman; Daniel W Visscher; Robert B Jenkins
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4307-15.
2010: Fredrik J Swartling; Matthew R Grimmer; Christopher S Hackett; Paul A Northcott; Qi-Wen Fan; David D Goldenberg; Jasmine Lau; Selma Masic; Kim Nguyen; Slava Yakovenko; Xiao-Ning Zhe; Heather C Flynn Gilmer; Rodney Collins; Mai Nagaoka; Joanna J Phillips; Robert B Jenkins; Tarik Tihan; Scott R Vandenberg; C David James; Kohichi Tanaka; Michael D Taylor; William A Weiss; Louis Chesler
Pleiotropic role for MYCN in medulloblastoma.
Genes & development 2010;24(10):1059-72.
2010: Aaron M Bender; Lara S Collier; Fausto J Rodriguez; Christina Tieu; Jon D Larson; Chandralekha Halder; Eric Mahlum; Thomas Kollmeyer; Keiko Akagi; Gobinda Sarkar; David A Largaespada; Robert B Jenkins
Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.
Cancer research 2010;70(9):3557-65.
2010: Monica M Reinholz; Jeanette E Eckel-Passow; S Keith Anderson; Yan W Asmann; Michael A Zschunke; Ann L Oberg; Ann E McCullough; Amylou Dueck; Beiyun Chen; Craig S April; Eliza Wickham-Garcia; Robert B Jenkins; Julie M Cunningham; Jin Jen; Edith A Perez; Jian-Bing Fan; Wilma L Lingle
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.
BMC medical genomics 2010;3():60.
2010: Latif Shooshtari Nasrin; Li Zhang; Erik P Sulman; J Matthew McDonald; Nasrin Latif Shooshtari; Andreana Rivera; Sonya Popoff; Catherine L Nutt; David N Louis; J Gregory Cairncross; Mark R Gilbert; Heidi S Phillips; Minesh Mehta; Arnab Chakravarti; Christopher E Pelloski; Krishna Bhat; Burt G Feuerstein; Robert B Jenkins; Kenneth Aldape
A multigene predictor of outcome in glioblastoma.
Neuro-oncology 2010;12(1):49-57.
2010: Xiaoke Wang; Renata Q Zamolyi; Hongying Zhang; Vera L Pannain; Fabiola Medeiros; Michele Erickson-Johnson; Robert B Jenkins; Andre M Oliveira
Fusion of HMGA1 to the LPP/TPRG1 intergenic region in a lipoma identified by mapping paraffin-embedded tissues.
Cancer genetics and cytogenetics 2010;196(1):64-7.
2009: David P Steensma; Jessemy D Neiger; Julie C Porcher; J Jonathan Keats; P Leif Bergsagel; Thomas R Dennis; Ryan A Knudson; Robert B Jenkins; Rafael Santana-Davila; Rajiv Kumar; Rhett P Ketterling
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.
Cancer research 2009;69(19):7518-23.
2009: Kristen L Drucker; Gaspar Kitange; Thomas Kollmeyer; Mark E Law; Sandra Passe; Amanda L Rynearson; Hilary Blair; Cheryl L Soderberg; Bruce W Morlan; Karla V Ballman; Caterina Giannini; Robert B Jenkins
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19.
Genes, chromosomes & cancer 2009;48(10):854-64.
2009: Fausto J Rodriguez; Renan A Mota; Bernd W Scheithauer; Caterina Giannini; Hilary Blair; Kent C New; Kevin J Wu; dennis dickson; Robert B Jenkins
Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Brain pathology (Zurich, Switzerland) 2009;19(4):623-9.
2009: Mine S Cicek; Susan L Slager; Sara J Achenbach; Amy J French; Hilary E Blair; Stephanie R Fink; Nathan R Foster; Brian Kabat; Kevin C Halling; Julie M Cunningham; James Cerhan; Robert B Jenkins; Lisa A Boardman; Gloria M Petersen; Daniel J Sargent; Steven R Alberts; Paul J Limburg; Stephen N Thibodeau
Functional and clinical significance of variants localized to 8q24 in colon cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2492-500.
2009: William R Sukov; Rhett P Ketterling; Donna J Lager; Austin W Carlson; Jason P Sinnwell; George K Chow; Robert B Jenkins; John C Cheville
CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Human pathology 2009;40(9):1296-303.
2009: Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joseph L Wiemels; Ping Yang; John K Wiencke
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
Nature genetics 2009;41(8):905-8.
2009: Xiaoke Wang; Rachael L Hulshizer; Michele Erickson-Johnson; Heather C Flynn; Robert B Jenkins; Ricardo V Lloyd; Andre M Oliveira
Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulation.
Genes, chromosomes & cancer 2009;48(8):673-8.
2009: Monica M Reinholz; Amy K Bruzek; Daniel W Visscher; Wilma L Lingle; Matthew J Schroeder; Edith A Perez; Robert B Jenkins
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.
The lancet oncology 2009;10(3):267-77.
2009: Fausto J Rodriguez; Bernd W Scheithauer; Lori A Erickson; Robert B Jenkins; Caterina Giannini
Ectopic low-grade adrenocortical carcinoma in the spinal region: immunohistochemical and molecular cytogenetic study of a pediatric case.
The American journal of surgical pathology 2009;33(1):142-8.
2008: Fausto J Rodriguez; Caterina Giannini; Yan W Asmann; Mukesh K Sharma; Arie Perry; Kathleen M Tibbetts; Robert B Jenkins; Bernd W Scheithauer; Shrikant Anant; Sarah Jenkins; Charles G Eberhart; Jann N. Sarkaria; David H Gutmann
Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
Journal of neuropathology and experimental neurology 2008;67(12):1194-204.
2008: Paul D. Brown; Sunil Krishnan; Jann N. Sarkaria; Wenting Wu; Kurt A Jaeckle; Joon H Uhm; Francois J Geoffroy; Robert M Arusell; Gaspar Kitange; Robert B Jenkins; John W Kugler; Roscoe F Morton; Kendrith M Rowland; Paul Mischel; William H Yong; Bernd W Scheithauer; David Schiff; Caterina Giannini; Jan C Buckner
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5603-9.
2008: Fausto J Rodriguez; Bernd W Scheithauer; Caterina Giannini; Sandra C Bryant; Robert B Jenkins
Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Cancer 2008;113(10):2779-89.
2008: Andrea K McCollum; Cynthia J Teneyck; Bridget Stensgard; Bruce W Morlan; Karla V Ballman; Robert B Jenkins; David O Toft; Charles Erlichman
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
Cancer research 2008;68(18):7419-27.
2008: Ricardo S Macarenco; Timothy S Uphoff; Heather Flynn Gilmer; Robert B Jenkins; Stephen N Thibodeau; Jean E Lewis; Julian R Molina; Ping Yang; Marie-Christine Aubry
Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic, and mutational analysis study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1168-75.
2008: Bora Gurel; Tsuyoshi Iwata; Cheryl M Koh; Robert B Jenkins; Fusheng Lan; Chi Dang; Jessica L Hicks; James Morgan; Toby C Cornish; Siobhan Sutcliffe; William B Isaacs; Jun Luo; Angelo M DeMarzo
Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(9):1156-67.
2008: Caterina Giannini; Peter C Burger; Brian A Berkey; J Gregory Cairncross; Robert B Jenkins; Minesh Mehta; Walter Curran; Kenneth Aldape
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.
Brain pathology (Zurich, Switzerland) 2008;18(3):360-9.
2008: Fausto J Rodriguez; Bernd W Scheithauer; Arie Perry; Andre M Oliveira; Robert B Jenkins; Angelica Oviedo; Sverre Mork; Cheryl A Palmer; Peter C Burger
Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
The American journal of surgical pathology 2008;32(5):699-709.
2008: Judith A Gilbert; Matthew P Goetz; Carol A Reynolds; James N Ingle; Karin F Giordano; Vera J Suman; Hilary E Blair; Robert B Jenkins; Wilma L Lingle; Monica M Reinholz; Alex A. Adjei; Matthew M Ames
Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
Molecular cancer therapeutics 2008;7(4):944-51.
2008: Tohru Nakagawa; Thomas Kollmeyer; Bruce W Morlan; S Keith Anderson; Eric J Bergstralh; Brian J Davis; Yan W Asmann; George G Klee; Karla V Ballman; Robert B Jenkins
A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy.
PloS one 2008;3(5):e2318.
2008: Fausto J Rodriguez; Stephen N Thibodeau; Robert B Jenkins; Karen V Schowalter; Bolette L Caron; Brian Patrick O'Neill; Charles David James; Charles David James; Sandra Passe; Jeffrey Slezak; Caterina Giannini
MGMT immunohistochemical expression and promoter methylation in human glioblastoma.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2008;16(1):59-65.
2007: Hongying Zhang; William D Macdonald; Michele Erickson-Johnson; Xiaoke Wang; Robert B Jenkins; Andre M Oliveira
Cytogenetic and molecular cytogenetic findings of intimal sarcoma.
Cancer genetics and cytogenetics 2007;179(2):146-9.
2007: W Edward Highsmith; Kevin J Meyer; Victoria M Marley; Robert B Jenkins
Conversion Technology for the separation of maternal and paternal copies of any autosomal chromosome in somatic cell hybrids.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2007;Chapter 3():Unit 3.6.
2007: Eric Mahlum; Deendayal Mandal; Chandralekha Halder; Avudaiappan Maran; Michael J Yaszemski; Robert B Jenkins; Mark E Bolander; Gobinda Sarkar
Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells.
Analytical biochemistry 2007;365(2):215-21.
2007: Ricardo S Macarenco; Michele Erickson-Johnson; Xiaoke Wang; Robert B Jenkins; Antonio G Nascimento; Andre M Oliveira
Cytogenetic and molecular cytogenetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Cancer genetics and cytogenetics 2007;172(2):147-50.
2006: Ricardo S Macarenco; Michele Erickson-Johnson; Xiaoke Wang; Robert B Jenkins; Antonio G Nascimento; Andre M Oliveira
Cytogenetic and molecular genetic findings in dedifferentiated liposarcoma with neural-like whorling pattern and metaplastic bone formation.
Cancer genetics and cytogenetics 2006;171(2):126-9.
2006: Robert B Jenkins; Hilary Blair; Karla V Ballman; Caterina Giannini; Robert M Arusell; Mark Law; Heather A Flynn; Sandra Passe; Sara Felten; Paul D. Brown; Edward G Shaw; Jan C Buckner
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Cancer research 2006;66(20):9852-61.
2006: Edith A Perez; Vera J Suman; Nancy E Davidson; Silvana Martino; Peter A Kaufman; Wilma L Lingle; Patrick J Flynn; James N Ingle; Daniel W Visscher; Robert B Jenkins
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3032-8.
2005: Edith A Perez; Vera J Suman; Kendrith M Rowland; James N Ingle; Muhammad Salim; Charles L Loprinzi; Patrick J Flynn; James A Mailliard; Carl G Kardinal; James E Krook; Abby R Thrower; Daniel W Visscher; Robert B Jenkins
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
Clinical breast cancer 2005;6(5):425-32.
2005: Edward Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1673-84.
2005: J Matthew McDonald; Siew-Ju See; Ivo W Tremont; Howard Colman; Mark R Gilbert; Morris Groves; Peter C Burger; David N Louis; Caterina Giannini; Gregory Fuller; Sandra Passe; Hilary Blair; Robert B Jenkins; Helen Yang; Alicia Ledoux; Joann Aaron; Ulka Tipnis; Wei Zhang; Kenneth Hess; Kenneth Aldape
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
Cancer 2005;104(7):1468-77.
2005: Evanthia C Galanis; Jan C Buckner; Matthew J Maurer; Jeffrey I Kreisberg; Karla V Ballman; Joseph P Boni; Josep M Peralba; Robert B Jenkins; Shaker R Dakhil; Roscoe F Morton; Kurt A Jaeckle; Bernd W Scheithauer; Janet Dancey; Manuel Hidalgo; Daniel J Walsh
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5294-304.
2005: Jason T Lewis; Rhett P Ketterling; Kevin C Halling; Carol Reynolds; Robert B Jenkins; Daniel W Visscher
Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining.
American journal of clinical pathology 2005;124(2):273-81.
2005: Mark E Law; Kristen L Templeton; Gaspar Kitange; Justin Smith; Anjan Misra; Burt Feuerstein; Robert B Jenkins
Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines.
Cancer genetics and cytogenetics 2005;160(1):1-14.
2005: Ping Yang; Thomas Kollmeyer; Kristin Buckner; William Bamlet; Karla V Ballman; Robert B Jenkins
Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
Cancer 2005;103(11):2363-72.
2005: Christopher E Pelloski; Anita Mahajan; Moshe H Maor; Eric L Chang; Shiao Woo; Mark Gilbert; Howard Colman; Helen Yang; Alicia Ledoux; Hilary Blair; Sandra Passe; Robert B Jenkins; Kenneth Aldape
YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3326-34.
2005: Gaspar Kitange; Anjan Misra; Mark Law; Sandra Passe; Thomas Kollmeyer; Matthew Maurer; Karla V Ballman; Burt Feuerstein; Robert B Jenkins
Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
Genes, chromosomes & cancer 2005;42(1):68-77.
2004: Camilo Adem; Cheryl L Soderberg; Kari Hafner; Carol Reynolds; Jeffrey M Slezak; Colleen S Sinclair; Thomas A Sellers; Daniel J Schaid; Fergus J. Couch; Lynn C Hartmann; Robert B Jenkins
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Genes, chromosomes & cancer 2004;41(1):1-11.
2003: Camilo Adem; Cheryl L Soderberg; Julie M Cunningham; Carol Reynolds; Thomas J Sebo; Stephen N Thibodeau; Lynn C Hartmann; Robert B Jenkins
Microsatellite instability in hereditary and sporadic breast cancers.
International journal of cancer. Journal international du cancer 2003;107(4):580-2.
2003: Gaspar Kitange; Kristen L Templeton; Robert B Jenkins
Recent advances in the molecular genetics of primary gliomas.
Current opinion in oncology 2003;15(3):197-203.
2003: Camilo Adem; Carol Reynolds; Cheryl L Soderberg; Jeffrey M Slezak; Shannon K McDonnell; Thomas J Sebo; Daniel J Schaid; Jeffrey L Myers; Thomas A Sellers; Lynn C Hartmann; Robert B Jenkins
Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Cancer 2003;97(1):1-11.
2002: Eric C Burton; Kathleen R Lamborn; Burt Feuerstein; Michael Prados; James Scott; Peter Forsyth; Sandra Passe; Robert B Jenkins; Kenneth Aldape
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
Cancer research 2002;62(21):6205-10.
2002: Brian Patrick O'Neill; Hannes Blondal; Ping Yang; Gudridur H Olafsdottir; Helgi Sigvaldason; Robert B Jenkins; David W Kimmel; Bernd W Scheithauer; Walter A Rocca; Johannes Bjornsson; Hrafn Tulinius
Risk of cancer among relatives of patients with glioma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(9):921-4.
2002: Christian Hartmann; Loki Johnk; Gaspar Kitange; Yanhong Wu; Linda K Ashworth; Robert B Jenkins; David N Louis
Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.
Cancer research 2002;62(14):4100-8.
2002: Colleen S Sinclair; Camilo Adem; Ali Naderi; Cheryl L Soderberg; Michele Johnson; Kangjian Wu; Linda Wadum; Vicki L Couch; Thomas A Sellers; Daniel J Schaid; Jeffrey Slezak; Zachary S Fredericksen; James N Ingle; Lynn Hartmann; Robert B Jenkins; Fergus J. Couch
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
Cancer research 2002;62(13):3587-91.
2002: Hiroko Kuriyama; Kathleen R Lamborn; Judith R O'Fallon; Nancy L Iturria; Thomas Sebo; Paul L Schaefer; Bernd W Scheithauer; Jan C Buckner; Nagato Kuriyama; Robert B Jenkins; Mark Israel
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Neuro-oncology 2002;4(3):179-86.
2002: Patrick C Roche; Vera J Suman; Robert B Jenkins; Nancy E Davidson; Silvana Martino; Peter A Kaufman; Ferdinand K Addo; Bronagh Murphy; James N Ingle; Edith A Perez
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.
Journal of the National Cancer Institute 2002;94(11):855-7.
2002: Norihiko Tsuchiya; Yasushi Kondo; Atsushi Takahashi; Hemant Pawar; Junqi Qian; Kazunari Sato; Michael M Lieber; Robert B Jenkins
Mapping and gene expression profile of the minimally overrepresented 8q24 region in prostate cancer.
The American journal of pathology 2002;160(5):1799-806.
2002: Kevin C Halling; Walter King; Irina A Sokolova; R Jeffrey Karnes; Reid G Meyer; Eric L Powell; Thomas J Sebo; John C Cheville; Amy C Clayton; Kelly L Krajnik; Thomas A Ebert; Robert E Nelson; Haleh M Burkhardt; Sanjay Ramakumar; Christopher S Stewart; V Shane Pankratz; Michael M Lieber; Michael L Blute; Horst Zincke; Steven A Seelig; Robert B Jenkins; Dennis J O'Kane
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
The Journal of urology 2002;167(5):2001-6.
2002: Christian Hartmann; Loki Johnk; Hikaru Sasaki; Robert B Jenkins; David N Louis
Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.
Brain pathology (Zurich, Switzerland) 2002;12(2):178-82.
2002: Greg D Eley; Jill L Reiter; Ajay Pandita; Soyeon Park; Robert B Jenkins; Nita Maihle; C David James
A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.
Neuro-oncology 2002;4(2):86-94.
2002: Edith A Perez; Patrick C Roche; Robert B Jenkins; Carol A Reynolds; Kevin C Halling; James N Ingle; Lester E Wold
HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization.
Mayo Clinic proceedings. Mayo Clinic 2002;77(2):148-54.
2002: Eric C Burton; Kathleen R Lamborn; Peter Forsyth; James Scott; Jason O'Campo; Jane Uyehara-Lock; Michael Prados; Mitchel Berger; Sandra Passe; Joon H Uhm; Brian P O'Neill; Robert B Jenkins; Kenneth Aldape
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(1):180-7.
2002: Junqi Qian; Kiyoshi Hirasawa; David G Bostwick; Erik J Bergstralh; Jeffrey M Slezak; Kari L Anderl; Thomas J Borell; Michael M Lieber; Robert B Jenkins
Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(1):35-44.
2001: Gaspar Kitange; JS Smith; Robert B Jenkins
Genetic alterations and chemotherapeutic response in human diffuse gliomas.
Expert review of anticancer therapy 2001;1(4):595-605.
2001: Lynn C Hartmann; Thomas A Sellers; Daniel J Schaid; T S Frank; Cheryl L Soderberg; DL Sitta; Marlene H Frost; Clive S Grant; John H Donohue; John E Woods; Shannon K McDonnell; Cate Walsh Vockley; Amie M Deffenbaugh; Fergus J. Couch; Robert B Jenkins
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
Journal of the National Cancer Institute 2001;93(21):1633-7.
2001: Peter C Burger; Dennis K Pearl; Kenneth Aldape; Allan J Yates; Bernd W Scheithauer; Sandra Passe; Robert B Jenkins; C D James
Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?
Journal of neuropathology and experimental neurology 2001;60(11):1099-104.
2001: Robert B Jenkins; Walter Curran; Charles B Scott; Gregory Cairncross
Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group.
American journal of clinical oncology 2001;24(5):506-8.
2001: Shannon K McDonnell; Daniel J Schaid; Jeffrey L Myers; Clive S Grant; John H Donohue; John E Woods; Marlene H Frost; Joanne L Johnson; DL Sitta; Jeffrey M Slezak; TB Crotty; Robert B Jenkins; Thomas A Sellers; Lynn C Hartmann
Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3938-43.
2001: Peter C Burger; A Y Minn; JS Smith; Thomas J Borell; Anne E Jedlicka; Brenda K Huntley; Patricia T Goldthwaite; Robert B Jenkins; Burt Feuerstein
Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(9):842-53.
2001: JS Smith; Issei Tachibana; Sandra Passe; Brenda K Huntley; Thomas J Borell; Nancy L Iturria; Judith R O'Fallon; Paul L Schaefer; Bernd W Scheithauer; C David James; Jan C Buckner; Robert B Jenkins
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Journal of the National Cancer Institute 2001;93(16):1246-56.
2001: Janice M Nigro; M A Takahashi; David Ginzinger; Mark Law; Sandra Passe; Robert B Jenkins; Kenneth Aldape
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
The American journal of pathology 2001;158(4):1253-62.
2000: H Jacobus Gilhuis; Kari L Anderl; Rudolf H Boerman; J M Jeuken; C David James; Corey Raffel; Bernd W Scheithauer; Robert B Jenkins
Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.
Clinical neurology and neurosurgery 2000;102(4):203-209.
2000: Kevin C Halling; Walter King; Irina A Sokolova; Reid G Meyer; Haleh M Burkhardt; A C Halling; John C Cheville; Thomas J Sebo; Sanjay Ramakumar; Christopher S Stewart; S Pankratz; Dennis J O'Kane; Steven A Seelig; Michael M Lieber; Robert B Jenkins
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
The Journal of urology 2000;164(5):1768-75.
2000: JS Smith; Issei Tachibana; HK Lee; Junqi Qian; U Pohl; Harvey W Mohrenweiser; Thomas J Borell; SM Hosek; Cheryl L Soderberg; A von Deimling; Arie Perry; Bernd W Scheithauer; David N Louis; Robert B Jenkins
Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers.
Genes, chromosomes & cancer 2000;29(1):16-25.
2000: Irina A Sokolova; Kevin C Halling; Robert B Jenkins; Haleh M Burkhardt; Reid G Meyer; Steven A Seelig; Walter King
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
The Journal of molecular diagnostics : JMD 2000;2(3):116-23.
2000: J S Smith; X Y Wang; J Qian; S M Hosek; Bernd W Scheithauer; Robert B Jenkins; C D James
Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features.
Journal of neuropathology and experimental neurology 2000;59(6):495-503.
2000: Issei Tachibana; JS Smith; K Sato; SM Hosek; David W Kimmel; Robert B Jenkins
Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
American journal of medical genetics 2000;92(2):136-41.
2000: JS Smith; Issei Tachibana; U Pohl; HK Lee; U Thanarajasingam; B P Portier; K Ueki; S Ramaswamy; SJ Billings; Harvey W Mohrenweiser; David N Louis; Robert B Jenkins
A transcript map of the chromosome 19q-arm glioma tumor suppressor region.
Genomics 2000;64(1):44-50.
2000: Keith C Bible; Scott A Boerner; K Kirkland; Kari L Anderl; D Bartelt; Phyllis A Svingen; Timothy J Kottke; Yean K Lee; S Eckdahl; P G Stalboerger; Robert B Jenkins; Scott H Kaufmann
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):661-70.
2000: JS Smith; Arie Perry; Thomas J Borell; HK Lee; Judith R O'Fallon; SM Hosek; David W Kimmel; A Yates; Peter C Burger; Bernd W Scheithauer; Robert B Jenkins
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):636-45.
2000: U Pohl; JS Smith; Issei Tachibana; K Ueki; HK Lee; S Ramaswamy; Qiang Wu; Harvey W Mohrenweiser; Robert B Jenkins; David N Louis
EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins.
Genomics 2000;63(2):255-62.
2000: JS Smith; Robert B Jenkins
Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications.
Frontiers in bioscience : a journal and virtual library 2000;5():D213-31.
1999: Corey Raffel; Linda M Frederick; Judith R O'Fallon; P Atherton-Skaff; A Perry; Robert B Jenkins; C David James
Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4085-90.
1999: Arie Perry; Kari L Anderl; Thomas J Borell; David W Kimmel; C H Wang; Judith R O'Fallon; Burt Feuerstein; Bernd W Scheithauer; Robert B Jenkins
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.
American journal of clinical pathology 1999;112(6):801-9.
1999: K Sato; Junqi Qian; Jeffrey M Slezak; Michael M Lieber; David G Bostwick; Erik J Bergstralh; Robert B Jenkins
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
Journal of the National Cancer Institute 1999;91(18):1574-80.
1999: N Peters; JS Smith; Issei Tachibana; HK Lee; U Pohl; B P Portier; David N Louis; Robert B Jenkins
The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss.
Neurogenetics 1999;2(3):163-6.
1999: C David James; Evanthia C Galanis; Linda M Frederick; David W Kimmel; Julie M Cunningham; P J Atherton-Skaff; Judith R O'Fallon; Robert B Jenkins; Jan C Buckner; Stephen B Hunter; Jeffrey J Olson; Bernd W Scheithauer
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
International journal of oncology 1999;15(3):547-53.
1999: Arie Perry; Robert B Jenkins; Judith R O'Fallon; Paul L Schaefer; David W Kimmel; Michelle R Mahoney; Bernd W Scheithauer; S M Smith; E M Hill; T J Sebo; Ralph Levitt; James E Krook; Loren K Tschetter; Roscoe F Morton; Jan C Buckner
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expression.
Cancer 1999;86(4):672-83.
1999: JS Smith; BE Alderete; YA Minn; Thomas J Borell; Arie Perry; G Mohapatra; SM Hosek; David W Kimmel; Judith R O'Fallon; A Yates; Burt Feuerstein; Peter C Burger; Bernd W Scheithauer; Robert B Jenkins
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Oncogene 1999;18(28):4144-52.
1999: JS Smith; Issei Tachibana; Cory Allen; Sharon Chiappa; HK Lee; Bryan McIver; Robert B Jenkins; Corey Raffel
Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus.
Genomics 1999;59(1):97-101.
1999: Akira Yokomizo; M Mai; David G Bostwick; Donald J Tindall; J Qian; Liang Cheng; Robert B Jenkins; David I Smith; Wanguo Liu
Mutation and expression analysis of the p73 gene in prostate cancer.
The Prostate 1999;39(2):94-100.
1999: J B Villeneuve; M Bradley Silverman; BE Alderete; William A Cliby; H Li; Gary A Croghan; Karl C Podratz; Robert B Jenkins
Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer.
Genes, chromosomes & cancer 1999;25(1):65-9.
1999: Fergus J. Couch; XY Wang; Guojun Wu ; Junqi Qian; Robert B Jenkins; C David James
Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.
Cancer research 1999;59(7):1408-11.
1999: Lynn C Hartmann; Daniel J Schaid; John E Woods; T P Crotty; Jeffrey L Myers; Philip G Arnold; Paul M Petty; Thomas A Sellers; Joanne L Johnson; Shannon K McDonnell; Marlene H Frost; Robert B Jenkins
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
The New England journal of medicine 1999;340(2):77-84.
1999: J Qian; Robert B Jenkins; David G Bostwick
Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
European urology 1999;35(5-6):479-83.
1998: David G Bostwick; A Shan; J Qian; M Darson; Nita Maihle; Robert B Jenkins; Liang Cheng
Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
Cancer 1998;83(9):1995-2002.
1998: Junqi Qian; Robert B Jenkins; David G Bostwick
Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(5):373-80.
1998: Evanthia C Galanis; Jan C Buckner; Robert P Dinapoli; Bernd W Scheithauer; Robert B Jenkins; C H Wang; Judith R O'Fallon; Gist Henry Farr
Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Journal of neurosurgery 1998;89(3):425-30.
1998: Akira Yokomizo; Donald J Tindall; Lynn Hartmann; Robert B Jenkins; David I Smith; Wanguo Liu
Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
International journal of oncology 1998;13(1):101-5.
1998: Michel Bahuau; Dominique Vidaud; Robert B Jenkins; Ivan Bièche; David W Kimmel; B Assouline; JS Smith; BE Alderete; J M Cayuela; J P Harpey; B Caille; Michel Vidaud
Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
Cancer research 1998;58(11):2298-303.
1998: Robert B Jenkins; J Qian; H K Lee; H Huang; K Hirasawa; David G Bostwick; J Proffitt; K Wilber; M M Lieber; Wanguo Liu; David I Smith
A molecular cytogenetic analysis of 7q31 in prostate cancer.
Cancer research 1998;58(4):759-66.
1998: H Huang; Chiping Qian; Robert B Jenkins; David I Smith
Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer.
Genes, chromosomes & cancer 1998;21(2):152-9.
1997: Wanguo Liu; C David James; Linda M Frederick; BE Alderete; Robert B Jenkins
PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
Cancer research 1997;57(23):5254-7.
1997: Junqi Qian; Robert B Jenkins; David G Bostwick
Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(11):1113-9.
1997: Arie Perry; T Nobori; N Ru; Kari L Anderl; Thomas J Borell; G Mohapatra; Burt Feuerstein; Robert B Jenkins; D A Carson
Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.
Journal of neuropathology and experimental neurology 1997;56(9):999-1008.
1997: James A Brown; Kari L Anderl; Thomas J Borell; Junqi Qian; David G Bostwick; Robert B Jenkins
Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
The Journal of urology 1997;158(2):370-4.
1997: Ayalew Tefferi; B J Bartholmai; Thomas E Witzig; Robert B Jenkins; Chin-Yang Li; Curtis A Hanson; R A Mesa; Robert L Phyliky
Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 1997;95(2):173-7.
1997: Corey Raffel; Robert B Jenkins; Linda M Frederick; David D Hebrink; BE Alderete; D W Fults; C David James
Sporadic medulloblastomas contain PTCH mutations.
Cancer research 1997;57(5):842-5.
1997: Caterina Giannini; Bernd W Scheithauer; Robert B Jenkins; Robert A Erlandson; Arie Perry; Thomas J Borell; R S Hoda; James M Woodruff
Soft-tissue perineurioma. Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature.
The American journal of surgical pathology 1997;21(2):164-73.
1997: Robert B Jenkins; J Qian; M M Lieber; David G Bostwick
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Cancer research 1997;57(3):524-31.
1997: Julie M Cunningham; David W Kimmel; Bernd W Scheithauer; Judith R O'Fallon; Paul J Novotny; Robert B Jenkins
Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value.
Journal of neurosurgery 1997;86(1):121-30.
1997: B M Gburek; T A Kollmorgen; Junqi Qian; S M D'Souza-Gburek; Michael M Lieber; Robert B Jenkins
Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization.
The Journal of urology 1997;157(1):223-7.
1996: C R Schad; D G Kuffel; William A Wyatt; Alan R Zinsmeister; Robert B Jenkins; Gordon W Dewald; Syed M Jalal
Application of fluorescent in situ hybridization with X and Y chromosome specific probes to buccal smear analysis.
American journal of medical genetics 1996;66(2):187-92.
1996: P C Lim; David J Tester; William A Cliby; SC Ziesmer; Patrick C Roche; L Hartmann; S N Thibodeau; K C Podratz; Robert B Jenkins
Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(11):1907-11.
1996: Junqi Qian; David G Bostwick; S Takahashi; Thomas J Borell; James A Brown; Michael M Lieber; Robert B Jenkins
Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens.
The American journal of pathology 1996;149(4):1193-9.
1996: Constantine Straturis; Robert B Jenkins; Elon Pras; C S Mitsiadis; S B Raff; P G Stalboerger; Constantine Tsigos; J Aidan Carney; George Chrousos
Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex).
The Journal of clinical endocrinology and metabolism 1996;81(10):3607-14.
1996: Julie M Cunningham; A Shan; Myra J Wick; Shannon K McDonnell; Daniel J Schaid; David J Tester; Junqi Qian; S Takahashi; Robert B Jenkins; David G Bostwick; S N Thibodeau
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cancer research 1996;56(19):4475-82.
1996: R H Boerman; Kari L Anderl; J Herath; Thomas J Borell; N Johnson; J Schaeffer-Klein; A Kirchhof; A K Raap; Bernd W Scheithauer; Robert B Jenkins
The glial and mesenchymal elements of gliosarcomas share similar genetic alterations.
Journal of neuropathology and experimental neurology 1996;55(9):973-81.
1996: James A Brown; S Takahashi; A Alcaraz; Thomas J Borell; Kari L Anderl; Junqi Qian; Diane L Persons; David G Bostwick; Michael M Lieber; Robert B Jenkins
Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.
The Journal of urology 1996;156(1):31-5.
1996: A Perry; Robert B Jenkins; R J Dahl; C A Moertel; Bernd W Scheithauer
Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications.
Cancer 1996;77(12):2567-73.
1996: Diane L Persons; R A Robinson; P H Hsu; S A Seelig; Thomas J Borell; Lynn C Hartmann; Robert B Jenkins
Chromosome-specific aneusomy in carcinoma of the breast.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):883-8.
1996: S Takahashi; A Alcaraz; James A Brown; Thomas J Borell; J F Herath; Erik J Bergstralh; Michael M Lieber; Robert B Jenkins
Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):137-45.
1996: Junqi Qian; Robert B Jenkins; David G Bostwick
Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization.
European urology 1996;30(2):177-84.
1995: Junqi Qian; David G Bostwick; S Takahashi; Thomas J Borell; J F Herath; Michael M Lieber; Robert B Jenkins
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
Cancer research 1995;55(22):5408-14.
1995: S Takahashi; A L Shan; S R Ritland; K A Delacey; David G Bostwick; Michael M Lieber; S N Thibodeau; Robert B Jenkins
Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
Cancer research 1995;55(18):4114-9.
1995: S Takahashi; Robert B Jenkins; M M Lieber
Cytogenetic analysis of prostate carcinoma by fluorescence in situ hybridization.
International journal of urology : official journal of the Japanese Urological Association 1995;2(4):215-23.
1995: Noralane M Lindor; P S Karnes; Virginia V Michels; Gordon W Dewald; J Goerss; Syed M Jalal; Robert B Jenkins; G Vockley; S N Thibodeau
Uniparental disomy in congenital disorders: a prospective study.
American journal of medical genetics 1995;58(2):143-6.
1995: S J Dalrymple; J F Herath; S R Ritland; C A Moertel; Robert B Jenkins
Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas.
Journal of neurosurgery 1995;83(2):316-23.
1995: S R Ritland; V Ganju; Robert B Jenkins
Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma.
Genes, chromosomes & cancer 1995;12(4):277-82.
1994: S J Dalrymple; Robert B Jenkins
Molecular genetics of astrocytomas and meningiomas.
Current opinion in neurology 1994;7(6):477-83.
1994: Diane L Persons; Lynn C Hartmann; J F Herath; Gary L Keeney; Robert B Jenkins
Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors.
American journal of clinical pathology 1994;102(6):775-9.
1994: James A Brown; A Alcaraz; S Takahashi; Diane L Persons; Michael M Lieber; Robert B Jenkins
Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.
The Journal of urology 1994;152(4):1157-62.
1994: S J Dalrymple; J F Herath; Thomas J Borell; C A Moertel; Robert B Jenkins
Correlation of cytogenetic and fluorescence in situ hybridization (FISH) studies in normal and gliotic brain.
Journal of neuropathology and experimental neurology 1994;53(5):448-56.
1994: V Ganju; Robert B Jenkins; Judith R O'Fallon; Bernd W Scheithauer; D T Ransom; J A Katzmann; David W Kimmel
Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers.
Cancer 1994;74(3):920-7.
1994: Thomas E Witzig; Thomas J Borell; J F Herath; A Tefferi; C Y Li; Robert B Jenkins
Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity.
Leukemia & lymphoma 1994;14(5-6):447-51.
1994: A Alcaraz; S Takahashi; James A Brown; J F Herath; Erik J Bergstralh; J J Larson-Keller; Michael M Lieber; Robert B Jenkins
Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.
Cancer research 1994;54(15):3998-4002.
1994: Diane L Persons; K Takai; D J Gibney; Jerry A Katzmann; Michael M Lieber; Robert B Jenkins
Comparison of fluorescence in situ hybridization with flow cytometry and static image analysis in ploidy analysis of paraffin-embedded prostate adenocarcinoma.
Human pathology 1994;25(7):678-83.
1994: S Takahashi; Junqi Qian; James A Brown; A Alcaraz; David G Bostwick; Michael M Lieber; Robert B Jenkins
Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
Cancer research 1994;54(13):3574-9.
1994: M K Dodson; William A Cliby; H J Xu; K A DeLacey; S X Hu; Gary L Keeney; J Li; Karl C Podratz; Robert B Jenkins; W F Benedict
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Cancer research 1994;54(3):610-3.
1994: S E Herath; P G Stalboerger; R J Dahl; Joseph E Parisi; Robert B Jenkins
Cytogenetic studies of four hemangiopericytomas.
Cancer genetics and cytogenetics 1994;72(2):137-40.
1993: Robert B Jenkins; D Bartelt; P Stalboerger; Diane L Persons; R J Dahl; K Podratz; G Keeney; L Hartmann
Cytogenetic studies of epithelial ovarian carcinoma.
Cancer genetics and cytogenetics 1993;71(1):76-86.
1993: M K Dodson; Lynn C Hartmann; William A Cliby; K A DeLacey; Gary L Keeney; S R Ritland; J Q Su; Karl C Podratz; Robert B Jenkins
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Cancer research 1993;53(19):4456-60.
1993: Gordon W Dewald; C R Schad; ER Christensen; Mark E Law; Alan R Zinsmeister; P G Stalboerger; Syed M Jalal; R C Ash; Robert B Jenkins
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation.
Bone marrow transplantation 1993;12(2):149-54.
1993: Diane L Persons; D J Gibney; Jerry A Katzmann; Michael M Lieber; G M Farrow; Robert B Jenkins
Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma.
The Journal of urology 1993;150(1):120-5.
1993: William A Cliby; G Sarkar; S R Ritland; Lynn Hartmann; Karl C Podratz; Robert B Jenkins
Absence of prohibitin gene mutations in human epithelial ovarian tumors.
Gynecologic oncology 1993;50(1):34-7.
1993: William A Cliby; S Ritland; Lynn Hartmann; M Dodson; Kevin C Halling; Gary L Keeney; Karl C Podratz; Robert B Jenkins
Human epithelial ovarian cancer allelotype.
Cancer research 1993;53(10 Suppl):2393-8.
1993: C A Moertel; R J Dahl; P G Stalboerger; David W Kimmel; Bernd W Scheithauer; Robert B Jenkins
Gliosis specimens contain clonal cytogenetic abnormalities.
Cancer genetics and cytogenetics 1993;67(1):21-7.
1993: Diane L Persons; Lynn C Hartmann; J F Herath; Thomas J Borell; William A Cliby; Gary L Keeney; Robert B Jenkins
Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
The American journal of pathology 1993;142(3):733-41.
1992: D T Ransom; S R Ritland; David W Kimmel; C A Moertel; R J Dahl; Bernd W Scheithauer; P J Kelly; Robert B Jenkins
Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Genes, chromosomes & cancer 1992;5(4):348-56.
1992: Noralane M Lindor; J A Ney; T A Gaffey; Robert B Jenkins; S N Thibodeau; Gordon W Dewald
A genetic review of complete and partial hydatidiform moles and nonmolar triploidy.
Mayo Clinic proceedings. Mayo Clinic 1992;67(8):791-9.
1992: W J Kraker; T J Borell; C R Schad; M J Pennington; P S Karnes; Gordon W Dewald; Robert B Jenkins
Fluorescent in situ hybridization: use of whole chromosome paint probes to identify unbalanced chromosome translocations.
Mayo Clinic proceedings. Mayo Clinic 1992;67(7):658-62.
1992: Robert B Jenkins; M M Le Beau; W J Kraker; T J Borell; P G Stalboerger; E M Davis; L Penland; A Fernald; R Espinosa; D J Schaid
Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens.
Blood 1992;79(12):3307-15.
1992: Olufunmilayo I Olopade; Robert B Jenkins; D T Ransom; K Malik; H Pomykala; T Nobori; J M Cowan; Janet D Rowley; Manuel O Diaz
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Cancer research 1992;52(9):2523-9.
1992: Marco A Pierotti; Massimo Santoro; Robert B Jenkins; Gabriella Sozzi; Italia Bongarzone; Michele Grieco; N Monzini; Monica Miozzo; M A Herrmann; A Fusco
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1616-20.
1991: M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; Robert B Jenkins
Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
The Journal of clinical investigation 1991;88(5):1596-604.
1991: M A Herrmann; I D Hay; D H Bartelt; J L Spurbeck; R J Dahl; C S Grant; Robert B Jenkins
Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1).
Cancer genetics and cytogenetics 1991;56(2):231-5.
1991: C R Schad; W J Kraker; Syed M Jalal; Martin S Tallman; H N Londer; L P Cook; Robert B Jenkins
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders.
American journal of clinical pathology 1991;96(2):203-10.
1990: Robert B Jenkins; I D Hay; J F Herath; C G Schultz; J L Spurbeck; C S Grant; J R Goellner; Gordon W Dewald
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.
Cancer 1990;66(6):1213-20.
1990: Kimm Hamann; R M Ten; David Loegering; Robert B Jenkins; M T Heise; C R Schad; Larry R Pease; G J Gleich; R L Barker
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily.
Genomics 1990;7(4):535-46.
1990: Gordon W Dewald; J L Diez-Martin; S L Steffen; Robert B Jenkins; P J Stupca; E O Burgert
Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
American journal of medical genetics. Supplement 1990;7():247-50.
1989: Robert B Jenkins; David W Kimmel; C A Moertel; C G Schultz; Bernd W Scheithauer; P J Kelly; Gordon W Dewald
A cytogenetic study of 53 human gliomas.
Cancer genetics and cytogenetics 1989;39(2):253-79.
1989: H S Schwartz; Robert B Jenkins; R J Dahl; Gordon W Dewald
Cytogenetic analyses on giant-cell tumors of bone.
Clinical orthopaedics and related research 1989;(240):250-60.